We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Revvity Inc (RVTY) USD1

Sell:$112.07 Buy:$112.10 Change: $0.92 (0.83%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:$112.07
Buy:$112.10
Change: $0.92 (0.83%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:$112.07
Buy:$112.10
Change: $0.92 (0.83%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.

Contact details

Address:
77 4Th Avenue
WALTHAM
02451
United States
Telephone:
+1 (781) 6636900
Website:
https://www.revvity.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
RVTY
ISIN:
US7140461093
Market cap:
$13.55 billion
Shares in issue:
121.70 million
Sector:
Life Sciences Tools & Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Prahlad Singh
    President, Chief Executive Officer, Director
  • Maxwell Krakowiak
    Chief Financial Officer, Senior Vice President
  • Joel Goldberg
    Senior Vice President - Administration, General Counsel, Secretary
  • Daniel Tereau
    Senior Vice President - Strategy and Business Development
  • Miriame Victor
    Chief Commercial Officer, Senior Vice President
  • Tajinder Vohra
    Senior Vice President - Global Operations
  • Anita Gonzales
    Vice President, Controller

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.